In the Czech Republic, the research & development by business enterprise, pharmaceutical industry in current ppp $ currently stands at 122.70 million, reflecting an increase of 7.98 million (7.0%) compared to 2021.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in the Czech Republic
No matching regions
Similar regions to the Czech Republic
Business R&D pharmaceutical in current PPP $
More indicators for the Czech Republic
Czech Republic Business R&D pharmaceutical in current PPP $ between 1996 and 2022
Period | Business R&D pharmaceutical in current PPP $ | Change |
---|---|---|
2022 | 122.70M | +7.98M |
2021 | 114.72M | +6.40M |
2020 | 108.33M | +5.02M |
2019 | 103.31M | -8.07M |
2018 | 111.37M | +21.79M |
2017 | 89.58M | -0.90M |
2016 | 90.48M | +3.59M |
2015 | 86.89M | +2.30M |
2014 | 84.59M | +7.65M |
2013 | 76.94M | -7.00M |
2012 | 83.94M | +3.28M |
2011 | 80.66M | +3.60M |
2010 | 77.06M | -10.15M |
2009 | 87.21M | +9.28M |
2008 | 77.93M | +0.92M |
2007 | 77.01M | +13.44M |
2006 | 63.57M | +8.49M |
2005 | 55.08M | -5.59M |
2004 | 60.67M | +22.88M |
2003 | 37.79M | -2.74M |
2002 | 40.53M | +10.56M |
2001 | 29.97M | +3.55M |
2000 | 26.42M | +8.60M |
1999 | 17.82M | +3.49M |
1998 | 14.33M | +3.33M |
1997 | 11.00M | -5.57M |
1996 | 16.57M |